GRFS : Summary for Grifols, S.A. - American Deposi - Yahoo Finance

U.S. Markets closed

Grifols, S.A. (GRFS)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.50+0.01 (+0.06%)
At close: 4:00PM EST
People also watch
IRWDSHPGAKRXPCRXEPZM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close17.49
Open17.43
Bid14.25 x 7000
Ask0.00 x
Day's Range17.31 - 17.50
52 Week Range14.27 - 17.56
Volume258,521
Avg. Volume755,809
Market Cap13.98B
Beta1.32
PE Ratio (TTM)42.22
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.39 (2.21%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire25 days ago

    Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million

    BARCELONA, Spain, Jan. 31, 2017 /PRNewswire/ --  The company consolidates a leading position of its Diagnostic Division enhancing its integration Grifols completes in record time the acquisition of the ...

  • PR Newswire25 days ago

    Hologic Completes Divestiture of Blood Screening Business

    MARLBOROUGH, Mass., Jan. 31, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash, the Company announced today. Hologic intends to discuss the financial effects of the transaction tomorrow, when it releases its quarterly financial results and provides updated financial guidance.

  • Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017
    Capital Cube26 days ago

    Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017

    Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing Grifols SA with the following peers – Baxter International Inc., China Biologic Products, Inc., Amgen Inc., China Cord Blood Corporation, Kimberly-Clark Corporation, Johnson & Johnson, Cord Blood America, Inc., Aradigm Corporation and Mylan N.V. (BAX-US, CBPO-US, AMGN-US, CO-US, KMB-US, JNJ-US, CBAI-US, ARDM-US and MYL-US). Grifols ... Read more (Read more...)